Cargando…
Loss of LZAP inactivates p53 and regulates sensitivity of cells to DNA damage in a p53-dependent manner
Chemotherapy and radiation, the two most common cancer therapies, exert their anticancer effects by causing damage to cellular DNA. However, systemic treatment damages DNA not only in cancer, but also in healthy cells, resulting in the progression of serious side effects and limiting efficacy of the...
Autores principales: | Wamsley, J J, Gary, C, Biktasova, A, Hajek, M, Bellinger, G, Virk, R, Issaeva, N, Yarbrough, W G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520489/ https://www.ncbi.nlm.nih.gov/pubmed/28394357 http://dx.doi.org/10.1038/oncsis.2017.12 |
Ejemplares similares
-
Selective antitumor activity of roscovitine in head and neck cancer
por: Gary, Cyril, et al.
Publicado: (2016) -
LZAP Inhibits p38 MAPK (p38) Phosphorylation and Activity by Facilitating p38 Association with the Wild-Type p53 Induced Phosphatase 1 (WIP1)
por: An, Hanbing, et al.
Publicado: (2011) -
p53 Signaling in Cancers
por: Issaeva, Natalia
Publicado: (2019) -
Global Genome Demethylation Causes Transcription-Associated DNA Double Strand Breaks in HPV-Associated Head and Neck Cancer Cells
por: Hajek, Michael, et al.
Publicado: (2020) -
Cas9 activates the p53 pathway and selects for p53-inactivating mutations
por: Enache, Oana M., et al.
Publicado: (2020)